MetaCap

Bruker (BRKR) vs Waters (WAT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bruker (BRKR) has outperformed Waters (WAT) over the past year, gaining 19.4% versus a gain of 11.8%. Over five years, WAT leads with a +30.1% price change compared with -32.2% for BRKR. Waters is the larger company by market cap ($86.56 billion vs $8.62 billion), about 10.0 times the size.

On valuation, Bruker trades at a lower forward P/E (23.3x vs 26.6x for Waters). Bruker pays a dividend yielding 0.09%, while Waters does not currently pay one. Waters converts more of its revenue into profit, with a net margin of 20.3% versus -0.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BRKR+19.44%WAT+11.79%
+44%+5%-34%
Nov 21, 20251 yearNov 20, 2026
BRKR-32.64%WAT+25.95%
+37%-16%-68%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BRKR versus WAT key metrics
MetricBRKRWAT
Share price$56.46$440.45
Market cap$8.62B$86.56B
1-day change-9.08%-3.51%
YTD return+19.85%+15.96%
1-year return+19.44%+11.79%
5-year return-32.16%+30.15%
P/E ratio (TTM)—184.29
Forward P/E23.2526.65
EPS (TTM)$-1.10$2.39
Dividend yield0.09%0.00%
Annual dividend$0.05$0.00
Revenue (latest FY)$3.44B$3.17B
Revenue growth (YoY)+2.08%+6.99%
Net income (latest FY)$-8.60M$642.63M
Gross margin45.91%59.28%
Operating margin1.98%25.36%
Net margin-0.25%20.30%
52-week high$68.98$483.33
52-week low$32.37$282.77
Distance from 52-week high-18.15%-8.87%
Analyst consensusbuybuy
Avg. price target upside+20.44%+14.27%
Average volume2.32M826.62K
Shares outstanding152.72M98.29M
Employees11,08515,000
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Waters is about 10.0 times larger than Bruker by market value ($86.56B vs $8.62B).
  • Waters is more profitable, keeping 20.3 cents of every revenue dollar as net income versus -0.3 cents for Bruker.

About Bruker

BRKR stock →

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees

About Waters

WAT stock →

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.

Industrials · Biotechnology: Laboratory Analytical Instruments · 15,000 employees

BRKR vs WAT FAQ

Which is bigger, Bruker or Waters?

Waters (WAT) is larger, with a market capitalization of $86.56B compared with $8.62B for Bruker (BRKR).

Which stock has performed better over the past year, BRKR or WAT?

BRKR returned +19.44% over the past 12 months, compared with +11.79% for WAT (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Bruker or Waters?

Bruker pays a dividend yielding 0.09%, while Waters does not currently pay a regular dividend.

Are Bruker and Waters in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons